Helicates meet Rotaxanes to create promise for future disease treatment

Scientists at the University of Birmingham have developed a new sensor to measure weak magnetic signals in the brain, which has the potential to increase understanding of connectivity in the brain, and detect signs of traumatic brain injury, dementia and schizophrenia.

Preventing serious complications from COVID-19 in potentially vulnerable populations in high risk environments, such as prisons, and preventing spread to surrounding communities needs a coordinated evidence-based approach to managing outbreaks of COVID-19 in prison settings.

A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again, for at least six months following their first infection.  The study, done as part of a major collaboration between the University of Oxford and Oxford University Hospitals (OUH) NHS Foundation Trust, was published today as a pre-print.

An international team of researchers from Bristol and China has prepared biocompatible protocells that generate nitric oxide gas - a known reagent for blood vessel dilation - that when placed inside blood vessels expand the biological tissue.